
Kevin M. Picardat
Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2813, 2825, 1104, 2899, 2822, 1763, 1732 |
| Total Applications | 2640 |
| Issued Applications | 2463 |
| Pending Applications | 47 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 864244
[patent_doc_number] => 07368272
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-05-06
[patent_title] => 'Expression of proteolytic enzymes in koji mold in the presence of carbon sources'
[patent_app_type] => utility
[patent_app_number] => 09/936367
[patent_app_country] => US
[patent_app_date] => 2000-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4107
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/368/07368272.pdf
[firstpage_image] =>[orig_patent_app_number] => 09936367
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/936367 | Expression of proteolytic enzymes in koji mold in the presence of carbon sources | Mar 1, 2000 | Issued |
Array
(
[id] => 1275413
[patent_doc_number] => 06649740
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-18
[patent_title] => 'Hydratable form of keratin for use as a soil amendment'
[patent_app_type] => B1
[patent_app_number] => 09/516755
[patent_app_country] => US
[patent_app_date] => 2000-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5078
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/649/06649740.pdf
[firstpage_image] =>[orig_patent_app_number] => 09516755
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/516755 | Hydratable form of keratin for use as a soil amendment | Feb 29, 2000 | Issued |
Array
(
[id] => 1584034
[patent_doc_number] => 06358513
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Method for treating Hashimoto\'s thyroiditis'
[patent_app_type] => B1
[patent_app_number] => 09/512110
[patent_app_country] => US
[patent_app_date] => 2000-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9560
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/358/06358513.pdf
[firstpage_image] =>[orig_patent_app_number] => 09512110
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/512110 | Method for treating Hashimoto's thyroiditis | Feb 23, 2000 | Issued |
Array
(
[id] => 758029
[patent_doc_number] => 07015192
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-21
[patent_title] => 'Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides'
[patent_app_type] => utility
[patent_app_number] => 10/030485
[patent_app_country] => US
[patent_app_date] => 2000-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5845
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015192.pdf
[firstpage_image] =>[orig_patent_app_number] => 10030485
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/030485 | Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides | Feb 17, 2000 | Issued |
| 09/499198 | Method of enhancement of neurologic recovery in human nervous system damage by use of pharmaceutical thrombopoietin | Feb 6, 2000 | Abandoned |
Array
(
[id] => 1300204
[patent_doc_number] => 06624140
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-23
[patent_title] => 'Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome'
[patent_app_type] => B1
[patent_app_number] => 09/493211
[patent_app_country] => US
[patent_app_date] => 2000-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11016
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/624/06624140.pdf
[firstpage_image] =>[orig_patent_app_number] => 09493211
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/493211 | Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome | Jan 27, 2000 | Issued |
Array
(
[id] => 623199
[patent_doc_number] => 07138127
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-11-21
[patent_title] => 'Clostridial toxin derivatives and methods for treating pain'
[patent_app_type] => utility
[patent_app_number] => 09/489667
[patent_app_country] => US
[patent_app_date] => 2000-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13068
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138127.pdf
[firstpage_image] =>[orig_patent_app_number] => 09489667
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/489667 | Clostridial toxin derivatives and methods for treating pain | Jan 18, 2000 | Issued |
Array
(
[id] => 1465917
[patent_doc_number] => 06458365
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'Method for treating headache'
[patent_app_type] => B1
[patent_app_number] => 09/487555
[patent_app_country] => US
[patent_app_date] => 2000-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4269
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458365.pdf
[firstpage_image] =>[orig_patent_app_number] => 09487555
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/487555 | Method for treating headache | Jan 18, 2000 | Issued |
Array
(
[id] => 963700
[patent_doc_number] => 06949512
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-09-27
[patent_title] => 'Therapeutic agent for the treatment of septicaemia its preparation and use'
[patent_app_type] => utility
[patent_app_number] => 09/484121
[patent_app_country] => US
[patent_app_date] => 2000-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 1032
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/949/06949512.pdf
[firstpage_image] =>[orig_patent_app_number] => 09484121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/484121 | Therapeutic agent for the treatment of septicaemia its preparation and use | Jan 12, 2000 | Issued |
Array
(
[id] => 1248801
[patent_doc_number] => 06673940
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-06
[patent_title] => 'Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids'
[patent_app_type] => B1
[patent_app_number] => 09/479279
[patent_app_country] => US
[patent_app_date] => 2000-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 19882
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673940.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479279
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479279 | Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids | Jan 5, 2000 | Issued |
Array
(
[id] => 1515395
[patent_doc_number] => 06420519
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Modifying tissue surfaces by liquid crystal formation'
[patent_app_type] => B1
[patent_app_number] => 09/446966
[patent_app_country] => US
[patent_app_date] => 1999-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3379
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420519.pdf
[firstpage_image] =>[orig_patent_app_number] => 09446966
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446966 | Modifying tissue surfaces by liquid crystal formation | Dec 28, 1999 | Issued |
Array
(
[id] => 1273302
[patent_doc_number] => 06649376
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-18
[patent_title] => 'Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display'
[patent_app_type] => B1
[patent_app_number] => 09/469194
[patent_app_country] => US
[patent_app_date] => 1999-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26564
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/649/06649376.pdf
[firstpage_image] =>[orig_patent_app_number] => 09469194
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/469194 | Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display | Dec 20, 1999 | Issued |
Array
(
[id] => 830193
[patent_doc_number] => 07399747
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-07-15
[patent_title] => 'Peptides carrying substances across the blood brain barrier'
[patent_app_type] => utility
[patent_app_number] => 09/857000
[patent_app_country] => US
[patent_app_date] => 1999-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6618
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/399/07399747.pdf
[firstpage_image] =>[orig_patent_app_number] => 09857000
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/857000 | Peptides carrying substances across the blood brain barrier | Nov 25, 1999 | Issued |
Array
(
[id] => 1221078
[patent_doc_number] => 06703480
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-09
[patent_title] => 'Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use'
[patent_app_type] => B1
[patent_app_number] => 09/449064
[patent_app_country] => US
[patent_app_date] => 1999-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15076
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/703/06703480.pdf
[firstpage_image] =>[orig_patent_app_number] => 09449064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/449064 | Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use | Nov 23, 1999 | Issued |
Array
(
[id] => 4379282
[patent_doc_number] => 06277580
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Species-specific genetic identification of Mycobacterium paratuberculosis'
[patent_app_type] => 1
[patent_app_number] => 9/440833
[patent_app_country] => US
[patent_app_date] => 1999-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8325
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277580.pdf
[firstpage_image] =>[orig_patent_app_number] => 440833
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/440833 | Species-specific genetic identification of Mycobacterium paratuberculosis | Nov 14, 1999 | Issued |
Array
(
[id] => 1307220
[patent_doc_number] => 06617307
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-09
[patent_title] => 'Peptide and osteogenetic accelerator'
[patent_app_type] => B1
[patent_app_number] => 09/439779
[patent_app_country] => US
[patent_app_date] => 1999-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6245
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617307.pdf
[firstpage_image] =>[orig_patent_app_number] => 09439779
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/439779 | Peptide and osteogenetic accelerator | Nov 11, 1999 | Issued |
Array
(
[id] => 1300192
[patent_doc_number] => 06624139
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-23
[patent_title] => 'Hypersensitive response elicitor-induced stress resistance'
[patent_app_type] => B1
[patent_app_number] => 09/431614
[patent_app_country] => US
[patent_app_date] => 1999-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23069
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/624/06624139.pdf
[firstpage_image] =>[orig_patent_app_number] => 09431614
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/431614 | Hypersensitive response elicitor-induced stress resistance | Nov 1, 1999 | Issued |
Array
(
[id] => 4328776
[patent_doc_number] => 06329504
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Antifungal polypeptide and methods for controlling plant pathogenic fungi'
[patent_app_type] => 1
[patent_app_number] => 9/428805
[patent_app_country] => US
[patent_app_date] => 1999-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28511
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329504.pdf
[firstpage_image] =>[orig_patent_app_number] => 428805
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/428805 | Antifungal polypeptide and methods for controlling plant pathogenic fungi | Oct 27, 1999 | Issued |
Array
(
[id] => 1406273
[patent_doc_number] => 06524585
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Indolicidin analogs and methods of using same'
[patent_app_type] => B1
[patent_app_number] => 09/416481
[patent_app_country] => US
[patent_app_date] => 1999-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 11061
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/524/06524585.pdf
[firstpage_image] =>[orig_patent_app_number] => 09416481
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416481 | Indolicidin analogs and methods of using same | Oct 11, 1999 | Issued |
Array
(
[id] => 1554213
[patent_doc_number] => 06348577
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-19
[patent_title] => 'Regulation of aureobasidin sensitivity in fungus'
[patent_app_type] => B1
[patent_app_number] => 09/414006
[patent_app_country] => US
[patent_app_date] => 1999-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 30690
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/348/06348577.pdf
[firstpage_image] =>[orig_patent_app_number] => 09414006
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414006 | Regulation of aureobasidin sensitivity in fungus | Oct 6, 1999 | Issued |